Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 6.16943135 |
2 | protein maturation by protein folding (GO:0022417) | 4.94142667 |
3 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.69792013 |
4 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.69792013 |
5 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.69792013 |
6 | metallo-sulfur cluster assembly (GO:0031163) | 4.66529181 |
7 | iron-sulfur cluster assembly (GO:0016226) | 4.66529181 |
8 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.59798280 |
9 | proteasome assembly (GO:0043248) | 4.51649234 |
10 | COPI coating of Golgi vesicle (GO:0048205) | 4.36034706 |
11 | Golgi transport vesicle coating (GO:0048200) | 4.36034706 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32502756 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32502756 |
14 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.26283766 |
15 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.19609192 |
16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.06452930 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02328915 |
18 | hepatocyte apoptotic process (GO:0097284) | 3.94521347 |
19 | purine nucleobase biosynthetic process (GO:0009113) | 3.92176848 |
20 | positive regulation of chromosome segregation (GO:0051984) | 3.82903161 |
21 | protein targeting to mitochondrion (GO:0006626) | 3.77835337 |
22 | eosinophil chemotaxis (GO:0048245) | 3.72708097 |
23 | negative regulation of Ras GTPase activity (GO:0034261) | 3.66828647 |
24 | autophagic vacuole fusion (GO:0000046) | 3.65067765 |
25 | ribosomal small subunit biogenesis (GO:0042274) | 3.64915253 |
26 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.61137455 |
27 | protein prenylation (GO:0018342) | 3.56557323 |
28 | prenylation (GO:0097354) | 3.56557323 |
29 | regulation of mononuclear cell migration (GO:0071675) | 3.50175280 |
30 | cellular response to zinc ion (GO:0071294) | 3.47905663 |
31 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.46168186 |
32 | establishment of protein localization to mitochondrion (GO:0072655) | 3.45676812 |
33 | protein localization to kinetochore (GO:0034501) | 3.45232188 |
34 | nucleobase biosynthetic process (GO:0046112) | 3.43588572 |
35 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.42091120 |
36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41229725 |
37 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.36040396 |
38 | NADH metabolic process (GO:0006734) | 3.34292847 |
39 | megakaryocyte development (GO:0035855) | 3.33361231 |
40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.33138461 |
41 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.33063318 |
42 | vesicle fusion (GO:0006906) | 3.32970077 |
43 | eosinophil migration (GO:0072677) | 3.29544702 |
44 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.29063109 |
45 | telomere maintenance via recombination (GO:0000722) | 3.28580617 |
46 | protein localization to mitochondrion (GO:0070585) | 3.25366806 |
47 | tolerance induction (GO:0002507) | 3.22805977 |
48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22590497 |
49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20958160 |
50 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.19889346 |
51 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.19889346 |
52 | non-recombinational repair (GO:0000726) | 3.19057856 |
53 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.19057856 |
54 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.19051426 |
55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16085251 |
56 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.15828638 |
57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14457194 |
58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14168876 |
59 | activated T cell proliferation (GO:0050798) | 3.13075495 |
60 | coenzyme A biosynthetic process (GO:0015937) | 3.12161809 |
61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11416615 |
62 | negative regulation of cell killing (GO:0031342) | 3.11416615 |
63 | B cell receptor signaling pathway (GO:0050853) | 3.10238152 |
64 | corticosteroid receptor signaling pathway (GO:0031958) | 3.05998757 |
65 | positive regulation of tolerance induction (GO:0002645) | 3.04881672 |
66 | mitotic sister chromatid cohesion (GO:0007064) | 3.03925214 |
67 | 7-methylguanosine mRNA capping (GO:0006370) | 3.03106492 |
68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.03104587 |
69 | peptidyl-lysine dimethylation (GO:0018027) | 3.00740165 |
70 | termination of RNA polymerase III transcription (GO:0006386) | 3.00491537 |
71 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.00491537 |
72 | organelle fusion (GO:0048284) | 2.99960126 |
73 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99657143 |
74 | DNA unwinding involved in DNA replication (GO:0006268) | 2.99073275 |
75 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.98804934 |
76 | axon extension involved in axon guidance (GO:0048846) | 2.98804934 |
77 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.98535503 |
78 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.97573142 |
79 | mitochondrial fusion (GO:0008053) | 2.95716252 |
80 | regulation of spindle organization (GO:0090224) | 2.93475631 |
81 | maturation of SSU-rRNA (GO:0030490) | 2.92958697 |
82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.92885400 |
83 | sodium ion export (GO:0071436) | 2.92727594 |
84 | negative regulation of phagocytosis (GO:0050765) | 2.92422432 |
85 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.91949782 |
86 | negative regulation of ligase activity (GO:0051352) | 2.91760652 |
87 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.91760652 |
88 | 7-methylguanosine RNA capping (GO:0009452) | 2.91161984 |
89 | RNA capping (GO:0036260) | 2.91161984 |
90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.88370008 |
91 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.88261850 |
92 | valine metabolic process (GO:0006573) | 2.88112512 |
93 | negative thymic T cell selection (GO:0045060) | 2.87971338 |
94 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.86251278 |
95 | GDP-mannose metabolic process (GO:0019673) | 2.86098018 |
96 | histone mRNA catabolic process (GO:0071044) | 2.85813581 |
97 | macrophage chemotaxis (GO:0048246) | 2.85755731 |
98 | pentose-phosphate shunt (GO:0006098) | 2.85517639 |
99 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.85251808 |
100 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84430614 |
101 | leukocyte cell-cell adhesion (GO:0007159) | 2.82254489 |
102 | negative T cell selection (GO:0043383) | 2.81281772 |
103 | regulation of T cell tolerance induction (GO:0002664) | 2.80861993 |
104 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.80715965 |
105 | establishment of nucleus localization (GO:0040023) | 2.80053910 |
106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79232171 |
107 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.78147522 |
108 | negative regulation of sodium ion transport (GO:0010766) | 2.78025336 |
109 | mitochondrial genome maintenance (GO:0000002) | 2.77851957 |
110 | negative regulation of fatty acid transport (GO:2000192) | 2.77814242 |
111 | regulation of sister chromatid cohesion (GO:0007063) | 2.77604558 |
112 | branch elongation of an epithelium (GO:0060602) | 2.77225264 |
113 | mitotic recombination (GO:0006312) | 2.77144385 |
114 | organelle membrane fusion (GO:0090174) | 2.76324501 |
115 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.76022768 |
116 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.74232433 |
117 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.74028093 |
118 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.72796907 |
119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72311861 |
120 | chaperone-mediated protein transport (GO:0072321) | 2.70710367 |
121 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70578907 |
122 | viral transcription (GO:0019083) | 2.70014995 |
123 | regulation of tolerance induction (GO:0002643) | 2.69932017 |
124 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.68594792 |
125 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.68594792 |
126 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.67896922 |
127 | protein localization to chromosome, centromeric region (GO:0071459) | 2.67511181 |
128 | establishment of endothelial barrier (GO:0061028) | 2.67210383 |
129 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67137330 |
130 | DNA strand elongation (GO:0022616) | 2.65475895 |
131 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.63916918 |
132 | regulation of RNA export from nucleus (GO:0046831) | 2.63544687 |
133 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.62640688 |
134 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.62640688 |
135 | tRNA modification (GO:0006400) | 2.62207361 |
136 | B cell homeostasis (GO:0001782) | 2.62087896 |
137 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.61857476 |
138 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.61857476 |
139 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61857476 |
140 | ncRNA 3-end processing (GO:0043628) | 2.61813673 |
141 | pentose metabolic process (GO:0019321) | 2.61495694 |
142 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.61482604 |
143 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.60164308 |
144 | translesion synthesis (GO:0019985) | 2.59550509 |
145 | regulation of protein heterodimerization activity (GO:0043497) | 2.59001995 |
146 | virion assembly (GO:0019068) | 2.58626519 |
147 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.57784789 |
148 | regulation of macrophage cytokine production (GO:0010935) | 2.57666592 |
149 | NLS-bearing protein import into nucleus (GO:0006607) | 2.57627914 |
150 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.57511267 |
151 | positive regulation of viral transcription (GO:0050434) | 2.55937454 |
152 | positive regulation of ligase activity (GO:0051351) | 2.55834816 |
153 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.55168915 |
154 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.55038885 |
155 | leukocyte aggregation (GO:0070486) | 2.54335690 |
156 | regulation of B cell differentiation (GO:0045577) | 2.54232723 |
157 | execution phase of apoptosis (GO:0097194) | 2.54068135 |
158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.53877274 |
159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.53155513 |
160 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52986742 |
161 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.52973008 |
162 | embryonic hemopoiesis (GO:0035162) | 2.51163095 |
163 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51112212 |
164 | protein targeting to lysosome (GO:0006622) | 2.50935116 |
165 | establishment of protein localization to vacuole (GO:0072666) | 2.50935116 |
166 | protein targeting to vacuole (GO:0006623) | 2.50935116 |
167 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.50857404 |
168 | snRNA processing (GO:0016180) | 2.49700922 |
169 | response to interleukin-15 (GO:0070672) | 2.49369655 |
170 | xenobiotic catabolic process (GO:0042178) | 2.48260418 |
171 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.47929189 |
172 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46044738 |
173 | regulation of erythrocyte differentiation (GO:0045646) | 2.45189698 |
174 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.44895628 |
175 | oxaloacetate metabolic process (GO:0006107) | 2.42922603 |
176 | positive regulation of interleukin-2 production (GO:0032743) | 2.41287690 |
177 | nuclear pore complex assembly (GO:0051292) | 2.41093340 |
178 | histone H3-K36 demethylation (GO:0070544) | 2.40516466 |
179 | T cell costimulation (GO:0031295) | 2.39995528 |
180 | hippo signaling (GO:0035329) | 2.39005504 |
181 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.37997887 |
182 | positive regulation of macrophage cytokine production (GO:0060907) | 2.36304034 |
183 | mitotic chromosome condensation (GO:0007076) | 2.35673256 |
184 | microtubule nucleation (GO:0007020) | 2.34179844 |
185 | lymphocyte costimulation (GO:0031294) | 2.34058930 |
186 | interferon-gamma production (GO:0032609) | 2.32253737 |
187 | tricarboxylic acid cycle (GO:0006099) | 2.31916755 |
188 | coronary vasculature morphogenesis (GO:0060977) | 2.30364679 |
189 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.30047415 |
190 | regulation of germinal center formation (GO:0002634) | 2.27834006 |
191 | histamine transport (GO:0051608) | 2.27325131 |
192 | histone-serine phosphorylation (GO:0035404) | 2.26424125 |
193 | heterotypic cell-cell adhesion (GO:0034113) | 2.26371300 |
194 | DNA topological change (GO:0006265) | 2.26145083 |
195 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.25780782 |
196 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.25780782 |
197 | lymph vessel development (GO:0001945) | 2.24799285 |
198 | activation of MAPKKK activity (GO:0000185) | 2.23766326 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.14830413 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.62060498 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.45897116 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.41577707 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.82243554 |
6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.53535338 |
7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.47457645 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 3.31473643 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.11452021 |
10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.08647067 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.08520197 |
12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.80109642 |
13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.79116465 |
14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.71416262 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69997050 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.67905177 |
17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.65904429 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.65209331 |
19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60033275 |
20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.57543975 |
21 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.52252871 |
22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.40165086 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36361057 |
24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33802497 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.31184802 |
26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.30770906 |
27 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26435221 |
28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20824272 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20462931 |
30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17945274 |
31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.07443675 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06576825 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.05934008 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05578308 |
35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04808806 |
36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97088553 |
37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96187492 |
38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91794898 |
39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89863729 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89494561 |
41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.89200543 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88492452 |
43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88266044 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 1.87579817 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84332247 |
46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83444371 |
47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82777923 |
48 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80728964 |
49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78909482 |
50 | MYB_26560356_Chip-Seq_TH1_Human | 1.77989290 |
51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.77594405 |
52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77230554 |
53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75911839 |
54 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75863707 |
55 | MYB_26560356_Chip-Seq_TH2_Human | 1.75376803 |
56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72525645 |
57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71715483 |
58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71193305 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69221028 |
60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.68126705 |
61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67863798 |
62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64312758 |
63 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62713535 |
64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61831615 |
65 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.59745365 |
66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58043760 |
67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57688459 |
68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57593809 |
69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54942735 |
70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54085690 |
71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53915255 |
72 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.49216599 |
73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48070624 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47849390 |
75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.46479537 |
76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45282908 |
77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42593971 |
78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42076776 |
79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41349417 |
80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40820249 |
81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40414360 |
82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40276114 |
83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39939966 |
84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37983251 |
85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37961120 |
86 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37495835 |
87 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.37185098 |
88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36348731 |
89 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36308150 |
90 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.35512223 |
91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35467542 |
92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34605208 |
93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33466068 |
94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33056259 |
95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32100349 |
96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31898550 |
97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.30411549 |
98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30355895 |
99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29742426 |
100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29108233 |
101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28220547 |
102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27771573 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27529177 |
104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27100183 |
105 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.27048681 |
106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26702126 |
107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25659472 |
108 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24495933 |
109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24205545 |
110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23412936 |
111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22130639 |
112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22073212 |
113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21934682 |
114 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21160601 |
115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20700653 |
116 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20087597 |
117 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18755691 |
118 | MAF_26560356_Chip-Seq_TH2_Human | 1.17998005 |
119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17987398 |
120 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17020305 |
121 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16536890 |
122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.15653192 |
123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15139082 |
124 | P68_20966046_ChIP-Seq_HELA_Human | 1.14723907 |
125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14482408 |
126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14391459 |
127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13340032 |
128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12594406 |
129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11425228 |
130 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09612506 |
131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09582953 |
132 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09286660 |
133 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08736516 |
134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06354227 |
135 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06062458 |
136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05487531 |
137 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04407057 |
138 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03941394 |
139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03531888 |
140 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03431609 |
141 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03270728 |
142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03254318 |
143 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02865901 |
144 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02692408 |
145 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02660489 |
146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02601515 |
147 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02275411 |
148 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02256607 |
149 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01684312 |
150 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01489771 |
151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01230354 |
152 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00648623 |
153 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00380114 |
154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99939559 |
155 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99664137 |
156 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98444694 |
157 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98117664 |
158 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97804765 |
159 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97631672 |
160 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97465153 |
161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97398519 |
162 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96996707 |
163 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95394656 |
164 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94126272 |
165 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92858777 |
166 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91148831 |
167 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90818474 |
168 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89971787 |
169 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89564745 |
170 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88748023 |
171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88373689 |
172 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88131291 |
173 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86227835 |
174 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85705460 |
175 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84030564 |
176 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83073728 |
177 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.82359036 |
178 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81760875 |
179 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.80995523 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.69573835 |
2 | MP0005451_abnormal_body_composition | 3.30770054 |
3 | MP0008260_abnormal_autophagy | 3.26947262 |
4 | MP0006082_CNS_inflammation | 3.15039537 |
5 | MP0002396_abnormal_hematopoietic_system | 3.10406195 |
6 | MP0003303_peritoneal_inflammation | 3.03926082 |
7 | MP0000566_synostosis | 3.01346930 |
8 | MP0003806_abnormal_nucleotide_metabolis | 2.94877026 |
9 | MP0004808_abnormal_hematopoietic_stem | 2.55463638 |
10 | MP0010352_gastrointestinal_tract_polyps | 2.55059627 |
11 | MP0008057_abnormal_DNA_replication | 2.44179508 |
12 | MP0008058_abnormal_DNA_repair | 2.42481591 |
13 | MP0003111_abnormal_nucleus_morphology | 2.29420102 |
14 | MP0005076_abnormal_cell_differentiation | 2.11538866 |
15 | MP0006036_abnormal_mitochondrial_physio | 2.08866849 |
16 | MP0008007_abnormal_cellular_replicative | 2.08542599 |
17 | MP0000858_altered_metastatic_potential | 1.99300467 |
18 | MP0003763_abnormal_thymus_physiology | 1.98570775 |
19 | MP0001545_abnormal_hematopoietic_system | 1.95086504 |
20 | MP0005397_hematopoietic_system_phenotyp | 1.95086504 |
21 | MP0000749_muscle_degeneration | 1.90503475 |
22 | MP0001800_abnormal_humoral_immune | 1.90479313 |
23 | MP0003123_paternal_imprinting | 1.89622276 |
24 | MP0000358_abnormal_cell_content/ | 1.83225365 |
25 | MP0005025_abnormal_response_to | 1.82908293 |
26 | MP0001835_abnormal_antigen_presentation | 1.81991312 |
27 | MP0008932_abnormal_embryonic_tissue | 1.78004438 |
28 | MP0003186_abnormal_redox_activity | 1.76591405 |
29 | MP0002398_abnormal_bone_marrow | 1.71969208 |
30 | MP0005671_abnormal_response_to | 1.69604587 |
31 | MP0002132_abnormal_respiratory_system | 1.67524519 |
32 | MP0006035_abnormal_mitochondrial_morpho | 1.67518811 |
33 | MP0005387_immune_system_phenotype | 1.66599823 |
34 | MP0001790_abnormal_immune_system | 1.66599823 |
35 | MP0002166_altered_tumor_susceptibility | 1.64968220 |
36 | MP0009053_abnormal_anal_canal | 1.64392954 |
37 | MP0009785_altered_susceptibility_to | 1.61477629 |
38 | MP0002420_abnormal_adaptive_immunity | 1.60319145 |
39 | MP0002452_abnormal_antigen_presenting | 1.60235145 |
40 | MP0008961_abnormal_basal_metabolism | 1.60094599 |
41 | MP0000678_abnormal_parathyroid_gland | 1.59346869 |
42 | MP0003329_amyloid_beta_deposits | 1.58416711 |
43 | MP0003787_abnormal_imprinting | 1.57947400 |
44 | MP0000750_abnormal_muscle_regeneration | 1.56903090 |
45 | MP0003943_abnormal_hepatobiliary_system | 1.55036943 |
46 | MP0001819_abnormal_immune_cell | 1.54119374 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.51461096 |
48 | MP0000703_abnormal_thymus_morphology | 1.50314235 |
49 | MP0004084_abnormal_cardiac_muscle | 1.50265048 |
50 | MP0002722_abnormal_immune_system | 1.47814973 |
51 | MP0004957_abnormal_blastocyst_morpholog | 1.47346532 |
52 | MP0003693_abnormal_embryo_hatching | 1.47334433 |
53 | MP0003786_premature_aging | 1.46508988 |
54 | MP0010368_abnormal_lymphatic_system | 1.46099024 |
55 | MP0006054_spinal_hemorrhage | 1.45919228 |
56 | MP0000689_abnormal_spleen_morphology | 1.45798989 |
57 | MP0000716_abnormal_immune_system | 1.44898756 |
58 | MP0001853_heart_inflammation | 1.44065886 |
59 | MP0004233_abnormal_muscle_weight | 1.43103381 |
60 | MP0000681_abnormal_thyroid_gland | 1.42762243 |
61 | MP0003705_abnormal_hypodermis_morpholog | 1.41886605 |
62 | MP0009278_abnormal_bone_marrow | 1.41841790 |
63 | MP0009840_abnormal_foam_cell | 1.40234572 |
64 | MP0005670_abnormal_white_adipose | 1.39157616 |
65 | MP0002723_abnormal_immune_serum | 1.37763310 |
66 | MP0003984_embryonic_growth_retardation | 1.33142990 |
67 | MP0001663_abnormal_digestive_system | 1.32404407 |
68 | MP0002405_respiratory_system_inflammati | 1.32030717 |
69 | MP0009333_abnormal_splenocyte_physiolog | 1.31651885 |
70 | MP0001919_abnormal_reproductive_system | 1.31578326 |
71 | MP0005166_decreased_susceptibility_to | 1.31553360 |
72 | MP0005501_abnormal_skin_physiology | 1.31347370 |
73 | MP0000467_abnormal_esophagus_morphology | 1.30542506 |
74 | MP0005000_abnormal_immune_tolerance | 1.30203733 |
75 | MP0000313_abnormal_cell_death | 1.28952702 |
76 | MP0002088_abnormal_embryonic_growth/wei | 1.28722463 |
77 | MP0002429_abnormal_blood_cell | 1.27960576 |
78 | MP0003077_abnormal_cell_cycle | 1.27613878 |
79 | MP0000350_abnormal_cell_proliferation | 1.27344597 |
80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27189673 |
81 | MP0003436_decreased_susceptibility_to | 1.26029664 |
82 | MP0002148_abnormal_hypersensitivity_rea | 1.25977351 |
83 | MP0003828_pulmonary_edema | 1.25556529 |
84 | MP0001873_stomach_inflammation | 1.24086188 |
85 | MP0000685_abnormal_immune_system | 1.22664849 |
86 | MP0002877_abnormal_melanocyte_morpholog | 1.20181217 |
87 | MP0001730_embryonic_growth_arrest | 1.19995412 |
88 | MP0003866_abnormal_defecation | 1.19757799 |
89 | MP0003075_altered_response_to | 1.19541358 |
90 | MP0004947_skin_inflammation | 1.19402984 |
91 | MP0002419_abnormal_innate_immunity | 1.15687319 |
92 | MP0003121_genomic_imprinting | 1.15036786 |
93 | MP0008877_abnormal_DNA_methylation | 1.11398319 |
94 | MP0000490_abnormal_crypts_of | 1.11320443 |
95 | MP0001661_extended_life_span | 1.11144328 |
96 | MP0001879_abnormal_lymphatic_vessel | 1.10913985 |
97 | MP0009384_cardiac_valve_regurgitation | 1.10095361 |
98 | MP0004858_abnormal_nervous_system | 1.10043053 |
99 | MP0010094_abnormal_chromosome_stability | 1.09289390 |
100 | MP0003453_abnormal_keratinocyte_physiol | 1.07317096 |
101 | MP0002090_abnormal_vision | 1.06898866 |
102 | MP0003566_abnormal_cell_adhesion | 1.06472037 |
103 | MP0010155_abnormal_intestine_physiology | 1.05423476 |
104 | MP0002006_tumorigenesis | 1.04530885 |
105 | MP0005058_abnormal_lysosome_morphology | 1.04460518 |
106 | MP0008469_abnormal_protein_level | 1.04028220 |
107 | MP0005499_abnormal_olfactory_system | 1.03979835 |
108 | MP0005394_taste/olfaction_phenotype | 1.03979835 |
109 | MP0002234_abnormal_pharynx_morphology | 1.03549524 |
110 | MP0004147_increased_porphyrin_level | 1.03150325 |
111 | MP0005381_digestive/alimentary_phenotyp | 1.02924280 |
112 | MP0001849_ear_inflammation | 1.01591957 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 0.99980574 |
114 | MP0010630_abnormal_cardiac_muscle | 0.99585875 |
115 | MP0010307_abnormal_tumor_latency | 0.97831741 |
116 | MP0001664_abnormal_digestion | 0.97802848 |
117 | MP0001672_abnormal_embryogenesis/_devel | 0.97106191 |
118 | MP0005380_embryogenesis_phenotype | 0.97106191 |
119 | MP0001727_abnormal_embryo_implantation | 0.94036856 |
120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93453050 |
121 | MP0001764_abnormal_homeostasis | 0.93131083 |
122 | MP0000343_altered_response_to | 0.92203666 |
123 | MP0001845_abnormal_inflammatory_respons | 0.92151740 |
124 | MP0002998_abnormal_bone_remodeling | 0.91830286 |
125 | MP0000013_abnormal_adipose_tissue | 0.91528159 |
126 | MP0005023_abnormal_wound_healing | 0.91381088 |
127 | MP0004484_altered_response_of | 0.90897716 |
128 | MP0002933_joint_inflammation | 0.89880468 |
129 | MP0000733_abnormal_muscle_development | 0.89820117 |
130 | MP0005187_abnormal_penis_morphology | 0.89316784 |
131 | MP0003448_altered_tumor_morphology | 0.89051906 |
132 | MP0000747_muscle_weakness | 0.88640738 |
133 | MP0000383_abnormal_hair_follicle | 0.88551560 |
134 | MP0003646_muscle_fatigue | 0.88452199 |
135 | MP0002086_abnormal_extraembryonic_tissu | 0.88446047 |
136 | MP0004036_abnormal_muscle_relaxation | 0.88416017 |
137 | MP0003091_abnormal_cell_migration | 0.88181147 |
138 | MP0004197_abnormal_fetal_growth/weight/ | 0.87648047 |
139 | MP0000604_amyloidosis | 0.87578409 |
140 | MP0001905_abnormal_dopamine_level | 0.87520433 |
141 | MP0005464_abnormal_platelet_physiology | 0.87347789 |
142 | MP0003122_maternal_imprinting | 0.87176955 |
143 | MP0001915_intracranial_hemorrhage | 0.86616458 |
144 | MP0002653_abnormal_ependyma_morphology | 0.86136557 |
145 | MP0004185_abnormal_adipocyte_glucose | 0.85850061 |
146 | MP0000759_abnormal_skeletal_muscle | 0.84951724 |
147 | MP0005384_cellular_phenotype | 0.84645724 |
148 | MP0005621_abnormal_cell_physiology | 0.84317614 |
149 | MP0001851_eye_inflammation | 0.83811558 |
150 | MP0002332_abnormal_exercise_endurance | 0.82819674 |
151 | MP0002019_abnormal_tumor_incidence | 0.82036720 |
152 | MP0001697_abnormal_embryo_size | 0.81865706 |
153 | MP0002128_abnormal_blood_circulation | 0.81797154 |
154 | MP0002925_abnormal_cardiovascular_devel | 0.81351149 |
155 | MP0009763_increased_sensitivity_to | 0.81260440 |
156 | MP0002080_prenatal_lethality | 0.80041033 |
157 | MP0002210_abnormal_sex_determination | 0.74639834 |
158 | MP0006292_abnormal_olfactory_placode | 0.71007359 |
159 | MP0005319_abnormal_enzyme/_coenzyme | 0.69556860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 5.34846319 |
2 | Progressive muscle weakness (HP:0003323) | 5.25212453 |
3 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.83427437 |
4 | Rhabdomyolysis (HP:0003201) | 3.53149456 |
5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52733192 |
6 | Abnormal gallbladder physiology (HP:0012438) | 3.48943216 |
7 | Cholecystitis (HP:0001082) | 3.48943216 |
8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.37217072 |
9 | Acute necrotizing encephalopathy (HP:0006965) | 3.27693949 |
10 | Ragged-red muscle fibers (HP:0003200) | 3.25285834 |
11 | Mitochondrial inheritance (HP:0001427) | 3.18316155 |
12 | Aplastic anemia (HP:0001915) | 3.17614705 |
13 | Hematochezia (HP:0002573) | 3.15902277 |
14 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.10510472 |
15 | Increased muscle lipid content (HP:0009058) | 3.05023911 |
16 | Exercise intolerance (HP:0003546) | 3.03228429 |
17 | Lactic acidosis (HP:0003128) | 3.00605741 |
18 | Recurrent viral infections (HP:0004429) | 2.97691257 |
19 | Short 4th metacarpal (HP:0010044) | 2.96088026 |
20 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.96088026 |
21 | Hypertensive crisis (HP:0100735) | 2.90454350 |
22 | Hepatocellular necrosis (HP:0001404) | 2.83456593 |
23 | Acute encephalopathy (HP:0006846) | 2.79029156 |
24 | Myoglobinuria (HP:0002913) | 2.74672719 |
25 | Microvesicular hepatic steatosis (HP:0001414) | 2.73665852 |
26 | Hepatic necrosis (HP:0002605) | 2.70046846 |
27 | Increased CSF lactate (HP:0002490) | 2.68574516 |
28 | IgM deficiency (HP:0002850) | 2.60286192 |
29 | Autoamputation (HP:0001218) | 2.60280117 |
30 | Increased serum lactate (HP:0002151) | 2.59094228 |
31 | Increased serum pyruvate (HP:0003542) | 2.58709809 |
32 | Vertebral arch anomaly (HP:0008438) | 2.58416928 |
33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.57222029 |
34 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.57222029 |
35 | Spontaneous hematomas (HP:0007420) | 2.55023868 |
36 | Progressive macrocephaly (HP:0004481) | 2.52810228 |
37 | Polycythemia (HP:0001901) | 2.51771851 |
38 | Recurrent fungal infections (HP:0002841) | 2.50778752 |
39 | Abnormality of the fingertips (HP:0001211) | 2.50579051 |
40 | Hypoplastic pelvis (HP:0008839) | 2.49406661 |
41 | Abnormality of glycolysis (HP:0004366) | 2.49383748 |
42 | Purpura (HP:0000979) | 2.48326961 |
43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.47228430 |
44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47189409 |
45 | Long foot (HP:0001833) | 2.46308978 |
46 | Megalencephaly (HP:0001355) | 2.45477928 |
47 | Trigonocephaly (HP:0000243) | 2.44610077 |
48 | Cutis marmorata (HP:0000965) | 2.43598706 |
49 | Renal Fanconi syndrome (HP:0001994) | 2.42919460 |
50 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.39025681 |
51 | Subacute progressive viral hepatitis (HP:0006572) | 2.38096289 |
52 | Shoulder girdle muscle weakness (HP:0003547) | 2.37370027 |
53 | Duplicated collecting system (HP:0000081) | 2.35544125 |
54 | Pelvic girdle muscle weakness (HP:0003749) | 2.34772825 |
55 | Papilloma (HP:0012740) | 2.34350468 |
56 | Verrucae (HP:0200043) | 2.34350468 |
57 | Colon cancer (HP:0003003) | 2.33281050 |
58 | Lymphopenia (HP:0001888) | 2.32438084 |
59 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.31061498 |
60 | Cerebral aneurysm (HP:0004944) | 2.30448040 |
61 | Prolonged neonatal jaundice (HP:0006579) | 2.29724272 |
62 | Increased cerebral lipofuscin (HP:0011813) | 2.28971041 |
63 | Hyperthyroidism (HP:0000836) | 2.27427077 |
64 | Cellulitis (HP:0100658) | 2.25855680 |
65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24953968 |
66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.24692794 |
67 | Truncus arteriosus (HP:0001660) | 2.24254390 |
68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.23182549 |
69 | Pustule (HP:0200039) | 2.22476013 |
70 | Chronic otitis media (HP:0000389) | 2.22382874 |
71 | Arterial tortuosity (HP:0005116) | 2.22194151 |
72 | Petechiae (HP:0000967) | 2.21918673 |
73 | Abnormality of the tricuspid valve (HP:0001702) | 2.21215998 |
74 | Reticulocytosis (HP:0001923) | 2.20953548 |
75 | Spondylolisthesis (HP:0003302) | 2.19592967 |
76 | Autoimmune thrombocytopenia (HP:0001973) | 2.19234229 |
77 | Myopathic facies (HP:0002058) | 2.17266325 |
78 | Respiratory failure (HP:0002878) | 2.17230805 |
79 | Generalized amyotrophy (HP:0003700) | 2.16645714 |
80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16266125 |
81 | Mitral stenosis (HP:0001718) | 2.15801609 |
82 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.15031782 |
83 | Menstrual irregularities (HP:0000858) | 2.14539772 |
84 | Pancytopenia (HP:0001876) | 2.13593662 |
85 | Abnormality of the 4th metacarpal (HP:0010012) | 2.12700941 |
86 | Emotional lability (HP:0000712) | 2.12358892 |
87 | Cerebral edema (HP:0002181) | 2.11380626 |
88 | Rectal prolapse (HP:0002035) | 2.10697268 |
89 | Narrow palate (HP:0000189) | 2.10635991 |
90 | Vertebral compression fractures (HP:0002953) | 2.08228857 |
91 | Persistence of primary teeth (HP:0006335) | 2.08091489 |
92 | Ankle contracture (HP:0006466) | 2.08056820 |
93 | Striae distensae (HP:0001065) | 2.07578338 |
94 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.07412341 |
95 | Respiratory difficulties (HP:0002880) | 2.07013575 |
96 | Bicuspid aortic valve (HP:0001647) | 2.06454397 |
97 | Abnormality of B cell number (HP:0010975) | 2.06342597 |
98 | B lymphocytopenia (HP:0010976) | 2.06342597 |
99 | Chorioretinal atrophy (HP:0000533) | 2.06331638 |
100 | Abnormality of the renal collecting system (HP:0004742) | 2.05507518 |
101 | Increased IgM level (HP:0003496) | 2.03714660 |
102 | Abnormal number of erythroid precursors (HP:0012131) | 2.03703565 |
103 | Cerebral hypomyelination (HP:0006808) | 2.03270504 |
104 | Abnormality of reticulocytes (HP:0004312) | 2.02633367 |
105 | Mucopolysacchariduria (HP:0008155) | 2.02600406 |
106 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02600406 |
107 | Broad distal phalanx of finger (HP:0009836) | 2.01946803 |
108 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01890925 |
109 | Aortic aneurysm (HP:0004942) | 2.01743597 |
110 | Degeneration of anterior horn cells (HP:0002398) | 2.01095074 |
111 | Abnormality of the anterior horn cell (HP:0006802) | 2.01095074 |
112 | Ureteral duplication (HP:0000073) | 2.00609631 |
113 | Recurrent abscess formation (HP:0002722) | 2.00601170 |
114 | Fatigue (HP:0012378) | 1.99592020 |
115 | Viral hepatitis (HP:0006562) | 1.99503582 |
116 | Gastrointestinal stroma tumor (HP:0100723) | 1.98786304 |
117 | Cholelithiasis (HP:0001081) | 1.98198265 |
118 | Esophageal neoplasm (HP:0100751) | 1.98018101 |
119 | Neoplasm of head and neck (HP:0012288) | 1.98018101 |
120 | Gastrointestinal carcinoma (HP:0002672) | 1.96805526 |
121 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.96805526 |
122 | Tetraplegia (HP:0002445) | 1.95848870 |
123 | T lymphocytopenia (HP:0005403) | 1.93735885 |
124 | Emphysema (HP:0002097) | 1.93719205 |
125 | Brushfield spots (HP:0001088) | 1.93472298 |
126 | Panhypogammaglobulinemia (HP:0003139) | 1.93369790 |
127 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93050478 |
128 | Acute myeloid leukemia (HP:0004808) | 1.92343013 |
129 | Abnormality of T cells (HP:0002843) | 1.92272129 |
130 | Macroorchidism (HP:0000053) | 1.92212862 |
131 | Vascular tortuosity (HP:0004948) | 1.91265835 |
132 | Recurrent bronchitis (HP:0002837) | 1.90652487 |
133 | Limb-girdle muscle atrophy (HP:0003797) | 1.90609838 |
134 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.90574678 |
135 | IgG deficiency (HP:0004315) | 1.90297129 |
136 | Opisthotonus (HP:0002179) | 1.89921017 |
137 | Periodontitis (HP:0000704) | 1.89723730 |
138 | Overfolded helix (HP:0000396) | 1.89650357 |
139 | Thyroiditis (HP:0100646) | 1.89005332 |
140 | Diaphragmatic weakness (HP:0009113) | 1.88719860 |
141 | Achilles tendon contracture (HP:0001771) | 1.88266539 |
142 | Abnormal platelet volume (HP:0011876) | 1.86908224 |
143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86906767 |
144 | Obstructive lung disease (HP:0006536) | 1.86906767 |
145 | Lymphedema (HP:0001004) | 1.86895246 |
146 | Increased serum ferritin (HP:0003281) | 1.85810993 |
147 | Agammaglobulinemia (HP:0004432) | 1.85725179 |
148 | Bladder neoplasm (HP:0009725) | 1.85723953 |
149 | Bladder carcinoma (HP:0002862) | 1.85723953 |
150 | Hyperammonemia (HP:0001987) | 1.85559088 |
151 | Eosinophilia (HP:0001880) | 1.85350914 |
152 | Long eyelashes (HP:0000527) | 1.85035868 |
153 | Hypoparathyroidism (HP:0000829) | 1.85028450 |
154 | Abnormally folded helix (HP:0008544) | 1.85001171 |
155 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.84505794 |
156 | Abnormality of T cell number (HP:0011839) | 1.84126898 |
157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83469504 |
158 | Osteolytic defects of the hand bones (HP:0009699) | 1.83469504 |
159 | Chest pain (HP:0100749) | 1.83274888 |
160 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.82891967 |
161 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.82891967 |
162 | Uterine leiomyosarcoma (HP:0002891) | 1.82562879 |
163 | Leiomyosarcoma (HP:0100243) | 1.82562879 |
164 | Leukocytosis (HP:0001974) | 1.82488012 |
165 | Combined immunodeficiency (HP:0005387) | 1.82410805 |
166 | Interstitial pulmonary disease (HP:0006530) | 1.81042219 |
167 | Ureteral stenosis (HP:0000071) | 1.80352635 |
168 | Severe muscular hypotonia (HP:0006829) | 1.78788646 |
169 | Myositis (HP:0100614) | 1.77895773 |
170 | Mesangial abnormality (HP:0001966) | 1.77432200 |
171 | Hepatosplenomegaly (HP:0001433) | 1.76932949 |
172 | Abnormality of eosinophils (HP:0001879) | 1.76242606 |
173 | Abnormality of macrophages (HP:0004311) | 1.75316389 |
174 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75188510 |
175 | Abnormality of the peritoneum (HP:0002585) | 1.75156108 |
176 | CNS demyelination (HP:0007305) | 1.74992815 |
177 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74982136 |
178 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74982136 |
179 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74982136 |
180 | Mediastinal lymphadenopathy (HP:0100721) | 1.74630984 |
181 | Type I transferrin isoform profile (HP:0003642) | 1.74491194 |
182 | Spinal cord lesions (HP:0100561) | 1.74217400 |
183 | Syringomyelia (HP:0003396) | 1.74217400 |
184 | Orchitis (HP:0100796) | 1.72911986 |
185 | Abnormality of the gallbladder (HP:0005264) | 1.72752155 |
186 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72398088 |
187 | Atelectasis (HP:0100750) | 1.72329933 |
188 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.69308419 |
189 | Transposition of the great arteries (HP:0001669) | 1.69308419 |
190 | Abnormal connection of the cardiac segments (HP:0011545) | 1.69308419 |
191 | Orthostatic hypotension (HP:0001278) | 1.68828906 |
192 | Dry hair (HP:0011359) | 1.67598582 |
193 | Increased connective tissue (HP:0009025) | 1.64222372 |
194 | Trismus (HP:0000211) | 1.63991972 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MKNK2 | 5.31900037 |
2 | TAOK2 | 4.18263642 |
3 | MAP3K11 | 3.89791224 |
4 | NME2 | 3.62893525 |
5 | TESK2 | 3.42406742 |
6 | MAP3K10 | 3.31471894 |
7 | MAP3K3 | 3.25330091 |
8 | STK10 | 3.10479795 |
9 | MAP4K1 | 2.96196897 |
10 | MKNK1 | 2.79458960 |
11 | ERN1 | 2.76344593 |
12 | TRIB3 | 2.66002575 |
13 | BUB1 | 2.59032046 |
14 | STK16 | 2.41289276 |
15 | TSSK6 | 2.36945434 |
16 | SRPK1 | 2.15439737 |
17 | CCNB1 | 2.10149160 |
18 | ABL2 | 2.03211954 |
19 | BCKDK | 1.93022533 |
20 | VRK2 | 1.88271344 |
21 | FGFR4 | 1.85574852 |
22 | TESK1 | 1.82605539 |
23 | NEK9 | 1.82024300 |
24 | ITK | 1.78426007 |
25 | FGFR2 | 1.76874827 |
26 | BRSK2 | 1.74650603 |
27 | TAOK1 | 1.74377824 |
28 | BRSK1 | 1.73268772 |
29 | IRAK3 | 1.73160763 |
30 | CSF1R | 1.67580184 |
31 | RPS6KA4 | 1.67365369 |
32 | LRRK2 | 1.62382626 |
33 | FGFR3 | 1.60618443 |
34 | CDC7 | 1.59522705 |
35 | PBK | 1.59428081 |
36 | CDK12 | 1.58851625 |
37 | EIF2AK1 | 1.54117729 |
38 | TGFBR2 | 1.44859769 |
39 | ZAP70 | 1.42099422 |
40 | SGK3 | 1.38334852 |
41 | PLK2 | 1.37080969 |
42 | TYRO3 | 1.33161403 |
43 | ICK | 1.27657497 |
44 | JAK1 | 1.26935810 |
45 | MAP3K1 | 1.25836688 |
46 | TYK2 | 1.23549388 |
47 | TXK | 1.23086404 |
48 | LIMK1 | 1.23081148 |
49 | PTK6 | 1.22023030 |
50 | ARAF | 1.19160648 |
51 | PIM2 | 1.18145545 |
52 | EEF2K | 1.17587047 |
53 | MARK3 | 1.16241683 |
54 | KIT | 1.15699510 |
55 | GRK6 | 1.14122296 |
56 | MST4 | 1.13719682 |
57 | AURKA | 1.12343626 |
58 | CDK6 | 1.07444242 |
59 | WEE1 | 1.07349997 |
60 | NEK1 | 1.07066020 |
61 | MAP3K8 | 1.05891233 |
62 | PRPF4B | 1.03527293 |
63 | DYRK1A | 1.02078979 |
64 | TEC | 1.01643246 |
65 | MAP2K3 | 0.99486344 |
66 | SIK3 | 0.98294192 |
67 | FRK | 0.98286329 |
68 | FGFR1 | 0.97365565 |
69 | SGK2 | 0.96875226 |
70 | CHUK | 0.96654307 |
71 | SIK1 | 0.96501651 |
72 | TLK1 | 0.96241114 |
73 | PRKCH | 0.95155524 |
74 | PDK2 | 0.94143655 |
75 | TTN | 0.94141186 |
76 | NTRK2 | 0.92821117 |
77 | SCYL2 | 0.92328812 |
78 | VRK1 | 0.91134285 |
79 | PAK3 | 0.89148284 |
80 | PDGFRA | 0.88795385 |
81 | ALK | 0.88208630 |
82 | CDK4 | 0.84842692 |
83 | BTK | 0.83239095 |
84 | TIE1 | 0.82623858 |
85 | MAP3K5 | 0.79378465 |
86 | PIM1 | 0.79087026 |
87 | TBK1 | 0.78129022 |
88 | MELK | 0.77764776 |
89 | PKN2 | 0.76797042 |
90 | SYK | 0.74722561 |
91 | DMPK | 0.74384329 |
92 | CSK | 0.74366418 |
93 | TGFBR1 | 0.73112811 |
94 | BRAF | 0.72408403 |
95 | PDGFRB | 0.69269944 |
96 | LCK | 0.69201221 |
97 | CHEK2 | 0.68869693 |
98 | SMG1 | 0.68381677 |
99 | RET | 0.68156057 |
100 | ZAK | 0.64151621 |
101 | MATK | 0.63715370 |
102 | JAK2 | 0.62961625 |
103 | NLK | 0.62665667 |
104 | HCK | 0.61048357 |
105 | ACVR1B | 0.59798619 |
106 | DAPK1 | 0.58920623 |
107 | MTOR | 0.58906201 |
108 | PAK1 | 0.57677949 |
109 | BRD4 | 0.57571874 |
110 | SGK494 | 0.56410218 |
111 | SGK223 | 0.56410218 |
112 | MAP2K7 | 0.55827259 |
113 | EPHA2 | 0.55446133 |
114 | KDR | 0.51651061 |
115 | STK4 | 0.51151780 |
116 | DAPK3 | 0.49716593 |
117 | CSNK1G2 | 0.48831539 |
118 | PLK3 | 0.47617760 |
119 | AURKB | 0.47406631 |
120 | PDK1 | 0.47354694 |
121 | PAK4 | 0.46536203 |
122 | LATS1 | 0.46061146 |
123 | ILK | 0.45636875 |
124 | BMX | 0.44006804 |
125 | EGFR | 0.43594870 |
126 | CSNK2A2 | 0.43281741 |
127 | ATR | 0.42237863 |
128 | MAPK11 | 0.41726683 |
129 | ERBB3 | 0.40938596 |
130 | IRAK4 | 0.40653218 |
131 | SRC | 0.40412001 |
132 | FES | 0.40226954 |
133 | RPS6KA5 | 0.39116034 |
134 | CAMK1D | 0.39061223 |
135 | AKT2 | 0.39038309 |
136 | STK24 | 0.38749085 |
137 | IGF1R | 0.37658091 |
138 | LYN | 0.37613921 |
139 | JAK3 | 0.36725391 |
140 | STK3 | 0.36265649 |
141 | FYN | 0.36140266 |
142 | CLK1 | 0.35879306 |
143 | MAPKAPK2 | 0.35070403 |
144 | CDK8 | 0.34954417 |
145 | MINK1 | 0.34592625 |
146 | CSNK1G3 | 0.34566679 |
147 | KSR1 | 0.34538582 |
148 | CDK7 | 0.34049135 |
149 | EPHB1 | 0.33440859 |
150 | PLK1 | 0.33090198 |
151 | CAMK2G | 0.33070989 |
152 | CDK11A | 0.32013328 |
153 | CSNK2A1 | 0.30812137 |
154 | TNK2 | 0.30804354 |
155 | CDK15 | 0.30177413 |
156 | CDK18 | 0.29304671 |
157 | RIPK4 | 0.27939287 |
158 | CHEK1 | 0.25487156 |
159 | RAF1 | 0.25409000 |
160 | CDK9 | 0.24884743 |
161 | MOS | 0.24513396 |
162 | CDK14 | 0.24108291 |
163 | DYRK1B | 0.23613455 |
164 | IKBKB | 0.22764096 |
165 | PRKCQ | 0.21763524 |
166 | TTK | 0.19813536 |
167 | PRKCD | 0.19271055 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.82816123 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.27542693 |
3 | RNA polymerase_Homo sapiens_hsa03020 | 3.12316403 |
4 | Ribosome_Homo sapiens_hsa03010 | 3.11179658 |
5 | DNA replication_Homo sapiens_hsa03030 | 3.10669441 |
6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.60525316 |
7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.59264200 |
8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.34901127 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.34382011 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28725611 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06691650 |
12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.04878716 |
13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.00125174 |
14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99837932 |
15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.95912574 |
16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93752081 |
17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83305159 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81075477 |
19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80953929 |
20 | Mismatch repair_Homo sapiens_hsa03430 | 1.79297196 |
21 | Cell cycle_Homo sapiens_hsa04110 | 1.75047309 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71654905 |
23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70971398 |
24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67509227 |
25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.66140310 |
26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.61265376 |
27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59176029 |
28 | Spliceosome_Homo sapiens_hsa03040 | 1.58892017 |
29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53941766 |
30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53516047 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53335843 |
32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53154081 |
33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.52198201 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51563112 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50802743 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48015348 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.46757378 |
38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.45143198 |
39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44991438 |
40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.43583108 |
41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43336315 |
42 | Measles_Homo sapiens_hsa05162 | 1.42393210 |
43 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41360588 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38468259 |
45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37285418 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37146853 |
47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35643506 |
48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35459859 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35305819 |
50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33270732 |
51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.29949271 |
52 | Tuberculosis_Homo sapiens_hsa05152 | 1.29004063 |
53 | Endometrial cancer_Homo sapiens_hsa05213 | 1.28071023 |
54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26739208 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24836750 |
56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22378053 |
57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20806436 |
58 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20733088 |
59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18779339 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17975222 |
61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.17946008 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17648353 |
63 | Shigellosis_Homo sapiens_hsa05131 | 1.17127572 |
64 | Glioma_Homo sapiens_hsa05214 | 1.16479889 |
65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14704767 |
66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.13427549 |
67 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13350503 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13100864 |
69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12925510 |
70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12750234 |
71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10891645 |
72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10865388 |
73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09343521 |
74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.07111419 |
75 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05673215 |
76 | Purine metabolism_Homo sapiens_hsa00230 | 1.05163517 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04316508 |
78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04052243 |
79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03854619 |
80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.03479118 |
81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01968055 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01327411 |
83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99860471 |
84 | Homologous recombination_Homo sapiens_hsa03440 | 0.99205913 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.98951079 |
86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97140980 |
87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96273460 |
88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95765999 |
89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95691622 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95291610 |
91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94572288 |
92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94523826 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.93368655 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.93279823 |
95 | RNA transport_Homo sapiens_hsa03013 | 0.93193368 |
96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92927044 |
97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92820914 |
98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91960841 |
99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91246317 |
100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90961183 |
101 | Apoptosis_Homo sapiens_hsa04210 | 0.88766497 |
102 | Prostate cancer_Homo sapiens_hsa05215 | 0.88129974 |
103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87836542 |
104 | Legionellosis_Homo sapiens_hsa05134 | 0.87805669 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87164353 |
106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86393605 |
107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85253248 |
108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85032169 |
109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84203040 |
110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83590371 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83568085 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.83453841 |
113 | Adherens junction_Homo sapiens_hsa04520 | 0.83449545 |
114 | Influenza A_Homo sapiens_hsa05164 | 0.82707498 |
115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80157029 |
116 | Hepatitis C_Homo sapiens_hsa05160 | 0.78330922 |
117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77572505 |
118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77111079 |
119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76730182 |
120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75619327 |
121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74056739 |
122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72805256 |
123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72779980 |
124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70671436 |
125 | Focal adhesion_Homo sapiens_hsa04510 | 0.70572038 |
126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69324283 |
127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69148101 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68308427 |
129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68247878 |
130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67331099 |
131 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67092925 |
132 | Salmonella infection_Homo sapiens_hsa05132 | 0.66885925 |
133 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64242925 |
134 | Phagosome_Homo sapiens_hsa04145 | 0.62354186 |
135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61246017 |
136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60314209 |
137 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59946902 |
138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59874552 |
139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58526884 |
140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58377182 |
141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58189029 |
142 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57849274 |
143 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57238587 |
144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57234840 |
145 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56548279 |
146 | Pertussis_Homo sapiens_hsa05133 | 0.55987360 |
147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55307031 |
148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54796110 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54399118 |
150 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53610382 |
151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53269478 |
152 | Malaria_Homo sapiens_hsa05144 | 0.52014608 |
153 | Phototransduction_Homo sapiens_hsa04744 | 0.51536112 |
154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48315846 |
155 | Peroxisome_Homo sapiens_hsa04146 | 0.47331835 |
156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46659797 |
157 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45317803 |
158 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41617804 |
159 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39069276 |
160 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38110299 |
161 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37012231 |
162 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35049161 |
163 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34602980 |
164 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33160002 |
165 | Alcoholism_Homo sapiens_hsa05034 | 0.33087922 |
166 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31348413 |
167 | Bladder cancer_Homo sapiens_hsa05219 | 0.30936953 |
168 | Prion diseases_Homo sapiens_hsa05020 | 0.30786809 |
169 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29495808 |
170 | Lysine degradation_Homo sapiens_hsa00310 | 0.27261136 |
171 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.24333792 |